These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17541523)

  • 21. Outcomes of a preoperative "bridging" strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration.
    Alshawabkeh LI; Prasad A; Lenkovsky F; Makary LF; Kandil ES; Weideman RA; Kelly KC; Rangan BV; Banerjee S; Brilakis ES
    EuroIntervention; 2013 Jun; 9(2):204-11. PubMed ID: 23454910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative management of antiplatelet agents.
    Mohr TS; Brouse SD
    Orthopedics; 2012 Aug; 35(8):687-91. PubMed ID: 22868592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet inhibition and bleeding complications in cardiac surgery: A review.
    Hansson EC; Jeppsson A
    Scand Cardiovasc J; 2016; 50(5-6):349-354. PubMed ID: 27590033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stents and IIb/IIIa receptor blockers combined: usefulness in various types of coronary artery disease.
    van der Wieken LR
    Semin Interv Cardiol; 1999 Jun; 4(2):77-83. PubMed ID: 10473876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy.
    Lippi G; Montagnana M; Danese E; Favaloro EJ; Franchini M
    Biomark Med; 2011 Feb; 5(1):63-70. PubMed ID: 21319966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
    Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
    Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes.
    Holmes LE; Gupta R; Rajendran S; Luu J; French JK; Juergens CP
    Cardiovasc Ther; 2016 Oct; 34(5):330-6. PubMed ID: 27327862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation.
    Vavalle JP; Rao SV
    Adv Cardiol; 2012; 47():125-40. PubMed ID: 22906908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy in acute coronary syndromes.
    Aragam KG; Bhatt DL
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):24-42. PubMed ID: 20924098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
    Yan BP; Gurvitch R; Ajani AE
    Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative management of patients with drug-eluting stents.
    Abualsaud AO; Eisenberg MJ
    JACC Cardiovasc Interv; 2010 Feb; 3(2):131-42. PubMed ID: 20170869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?
    Mahla E; Prueller F; Farzi S; Pregartner G; Raggam RB; Beran E; Toller W; Berghold A; Tantry US; Gurbel PA
    Ann Thorac Surg; 2016 Dec; 102(6):2010-2017. PubMed ID: 27378554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy.
    D'Urbano M; Barlocco F; Poli A; Fetiveau R; Vandoni P; Savonitto S; De Servi S
    J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):737-41. PubMed ID: 18545078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative management of antiplatelet therapy.
    Oprea AD; Popescu WM
    Br J Anaesth; 2013 Dec; 111 Suppl 1():i3-17. PubMed ID: 24335397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of perioperative antiplatelet therapy and platelet reactivity testing in carotid revascularization: overview of the evidence.
    Leunissen TC; De Borst GJ; Janssen PW; ten Berg JM
    J Cardiovasc Surg (Torino); 2015 Apr; 56(2):165-75. PubMed ID: 25600432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms.
    Kono K; Shintani A; Yoshimura R; Okada H; Tanaka Y; Fujimoto T; Tomura N; Terada T
    Acta Neurochir (Wien); 2013 Aug; 155(8):1549-57. PubMed ID: 23715948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy.
    Denardo SJ; Davis KE; Tcheng JE
    Am Heart J; 2005 Jan; 149(1):138-44. PubMed ID: 15660045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.
    Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A
    Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.